This brand name is authorized in Austria, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Turkey, United Kingdom, United States
The drug VPRIV contains one active pharmaceutical ingredient (API):
|
1
Velaglucerase alfa
UNII 23HYE36B0I - VELAGLUCERASE ALFA
|
|
Velaglucerase alfa supplements or replaces beta-glucocerebrosidase, the enzyme that catalyzes the hydrolysis of glucocerebroside to glucose and ceramide in the lysosome, reducing the amount of accumulated glucocerebroside and correcting the pathophysiology of Gaucher disease. Velaglucerase alfa increases haemoglobin concentration and platelet counts and reduces liver and spleen volumes in patients with type 1 Gaucher disease. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| VPRIV Powder for solution for infusion | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A16AB10 | Velaglucerase alfa | A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AB Enzymes |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 501121020037817 |
| Country: CA | Health Products and Food Branch | Identifier(s): 02357119 |
| Country: EE | Ravimiamet | Identifier(s): 1492040, 1588473, 1588484 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 10646002 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 103528 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 65369582 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 182451 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 6707 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 040424018, 040424020 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 3959416F1020 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1056324, 1061958, 1061959 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 91618 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 17445 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100235510 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W68150001 |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699943790073, 8699943790080, 8699943790097 |
| Country: US | FDA, National Drug Code | Identifier(s): 54092-701 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
